Companies / cabio-biotech

Cabio Biotech

ChinaTechnology & Electronics

Overview

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. It offers human and animal nutrition, personal care, and synthetic biology products. The company was founded in 1999 and is based in Wuhan, the People's Republic of China.

Employees595
Market Cap$2.1B
Revenue$418.2M
Listed OnShanghai Stock Exchange
Ticker688089
CEOMr. Dewei Yi
HeadquartersWuhan

Website

https://www.cabio.cn